https://pharmoniq.com/news/fda-approves-merck-kgaa-pimicotinib-tgct-joint-tumour PharmoniQ en 2026-11-11T13:59:20.395Z FDA Approves Merck KGaA Tumour Pill After 56% Respond in Trial FDA approval, Merck KGaA, EMD Serono, Abbisko, TGCT https://pharmoniq.com/news/argenx-buys-unnatural-products-peptide-biotech-1-15b PharmoniQ en 2026-11-11T08:04:48.609Z Argenx to Pay $550M Upfront in Up to $1.15B Peptide Biotech Buyout argenx, Unnatural Products, acquisitions, peptides, immunology https://pharmoniq.com/news/lantheus-to-sell-new-jersey-radiopharma-plant-and-cdmo-to-pharmalogic PharmoniQ en 2026-11-10T14:03:43.056Z Lantheus to Sell New Jersey Radiopharma Plant and CDMO to PharmaLogic radiopharmaceuticals, CDMO, Lantheus, PharmaLogic, lutetium-177 https://pharmoniq.com/news/fda-approves-bayer-sunharbo-asundexian-stroke-risk PharmoniQ en 2026-11-10T08:03:19.109Z FDA Approves Bayer's Sunharbo After It Cut Stroke Risk 26% Bayer, FDA approval, stroke, asundexian, Factor XIa